Article ID Journal Published Year Pages File Type
8442043 European Journal of Cancer 2015 7 Pages PDF
Abstract
The follow-up schedules are best tailored with the risk of recurrence. The risk of recurrence should be estimated with the prognostic tools that consider the most relevant prognostic factors.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery
Authors
, , , , , ,